INCASSIA Drug Patent Profile
✉ Email this page to a colleague
When do Incassia patents expire, and what generic alternatives are available?
Incassia is a drug marketed by Aurobindo Pharma and is included in one NDA.
The generic ingredient in INCASSIA is norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the norethindrone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Incassia
A generic version of INCASSIA was approved as norethindrone by GLENMARK PHARMS LTD on July 22nd, 2010.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for INCASSIA?
- What are the global sales for INCASSIA?
- What is Average Wholesale Price for INCASSIA?
Summary for INCASSIA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 3,815 |
| Drug Prices: | Drug price information for INCASSIA |
| DailyMed Link: | INCASSIA at DailyMed |
Pharmacology for INCASSIA
| Drug Class | Progestin |
US Patents and Regulatory Information for INCASSIA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | INCASSIA | norethindrone | TABLET;ORAL-28 | 207304-001 | Sep 23, 2016 | AB1 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
